These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 856532)

  • 21. 99Tcm-labelled chimeric human/mouse anti-granulocyte antibody bone marrow scintigraphy: a preliminary clinical study.
    Higuchi T; Inoue T; Sarwar M; Oriuchi N; Karasawa M; Naruse T; Yamanaka H; Watanabe T; Chung JK; Endo K
    Nucl Med Commun; 1998 May; 19(5):463-74. PubMed ID: 9853336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone scanning in management of metastatic osteogenic sarcoma.
    Siddiqui AR; Wellman HN; Weetman RM; Smith WL
    Clin Nucl Med; 1979 Jan; 4(1):6-11. PubMed ID: 283899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for bone metastases. Are only scans necessary?
    McDougall IR; Kriss JP
    JAMA; 1975 Jan; 231(1):46-50. PubMed ID: 1243567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of bone scanning in the staging of breast cancer.
    Kirkman S; Henk JM
    Clin Radiol; 1979 Jan; 30(1):11-4. PubMed ID: 421415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skeletal scintigraphy following incidental trauma.
    Kim HR; Thrall JH; Keyes JW
    Radiology; 1979 Feb; 130(2):447-51. PubMed ID: 760163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radionuclide evaluation of skeletal metastases: practical considerations.
    Gold RH; Bassett LW
    Skeletal Radiol; 1986; 15(1):1-9. PubMed ID: 3941915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. I. Incidence of bone metastases from bronchogenic carcinoma and their prognosis (author's transl)].
    Fujimura N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Nov; 38(11):1054-63. PubMed ID: 733476
    [No Abstract]   [Full Text] [Related]  

  • 28. Bone scintigraphy in plasma-cell myeloma. A prospective study of 70 patients.
    Bataille R; Chevalier J; Rossi M; Sany J
    Radiology; 1982 Dec; 145(3):801-4. PubMed ID: 6292996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison between traditional skeletal radiography and total body bone scintigraphy in the diagnosis of multiple myeloma].
    Scutellari PN; Spanedda R; Feggi LM; Calzolari F; Cervi PM
    Radiol Med; 1984 May; 70(5):271-6. PubMed ID: 6531460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skeletal scanning in neoplastic disease.
    O'Mara RE
    Cancer; 1976 Jan; 37(1 suppl):480-6. PubMed ID: 1247979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technetium-99m labelled imidodiphosphate: an improved bone-scanning radiopharmaceutical.
    Brody KR; Hosain P; Spencer RP; Hosain F; Wagner HN
    Br J Radiol; 1976 Mar; 49(579):267-9. PubMed ID: 179654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary experience of bone scanning with 99mTc-labelled polyphosphate in malignant disease.
    Citrin DL; Greig WR; Calder JF; Bessent RG; Tuohy JB; Blumgart LH
    Br J Surg; 1974 Jan; 61(1):73-5. PubMed ID: 4359623
    [No Abstract]   [Full Text] [Related]  

  • 33. [Skeletal scintigraphy using pyrophosphate 99mTc].
    Zubovskiĭ GA; Turaev RN; Khripta FP; Aslanov IaI
    Med Radiol (Mosk); 1978 Feb; 23(2):32-7. PubMed ID: 204849
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bone metastases from breast cancer as detected by bone scintigraphy with 99mTc-phosphorous compounds (author's transl)].
    Fujimura N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 May; 38(5):449-56. PubMed ID: 693261
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of radiography and isotopic scintigraphy for detecting skeletal metastases in breast cancer.
    Roberts JG; Gravelle IH; Baum M; Bligh AS; Leach KG; Hughes LE
    Lancet; 1976 Jan; 1(7953):237-9. PubMed ID: 55541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [NMR tomography in plasmacytoma].
    Linden A; Gückel C; Widder R; Jungehülsing M; Diehl V; Schicha H
    Rofo; 1992 Jan; 156(1):83-8. PubMed ID: 1733480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of bone metastases in urogenital malignancies utilizing 99mTc-labeled phosphate compounds.
    Parthasarathy KL; Landsberg R; Bakshi SP; Donoghue G; Merrin C
    Urology; 1978 Jan; 11(1):99-102. PubMed ID: 622775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of skeletal metastases.
    Merrick MV
    Br J Radiol; 1973 Jan; 46(541):76. PubMed ID: 4683338
    [No Abstract]   [Full Text] [Related]  

  • 39. What is the significance of solitary bony abnormalities on bone scintigrams of children with malignancy?
    Freeman SJ; Sonoda LI; Seshadri N; Howard W; Set PA; Balan KK
    Pediatr Hematol Oncol; 2010 Aug; 27(5):380-6. PubMed ID: 20469974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
    Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
    Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.